NCT01975480View on ClinicalTrials.gov

Efficacy of SNRI Treatment on Prefrontality in Patients With GAD and Other Comorbities

PHASE4CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

April 15, 2020

Study Completion Date

May 1, 2020

Conditions
Generalized Anxiety Disorder
Interventions
DRUG

Desvenlafaxine

Trial Locations (1)

M4W 2N4

START Clinic for Mood and Anxiety Disorders, Toronto

All Listed Sponsors
lead

START Clinic for Mood and Anxiety Disorders

OTHER

NCT01975480 - Efficacy of SNRI Treatment on Prefrontality in Patients With GAD and Other Comorbities | Biotech Hunter | Biotech Hunter